LOGO BMT (Pylera 140 mg-125 mg-125 mg)
Generic Name: bismuth subcitrate potassium/metronidazole/tetracycline
Pill imprint LOGO BMT has been identified as Pylera 140 mg-125 mg-125 mg.
Pylera is used in the treatment of helicobacter pylori infection and belongs to the drug class H. pylori eradication agents. There is positive evidence of human fetal risk during pregnancy. Pylera 140 mg-125 mg-125 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for LOGO BMT (Pylera 140 mg-125 mg-125 mg)
- Generic Name:
- bismuth subcitrate potassium/metronidazole/tetracycline
- 140 mg-125 mg-125 mg
- Prescription only
- Drug Class:
- H. pylori eradication agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Axcan Scandipharm Inc.
More about Pylera (bismuth subcitrate potassium / metronidazole / tetracycline)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...